Pacira BioSciences, Inc.
PCRX
$21.67
-$1.03-4.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -50.80% | -45.72% | 10.30% | 51.47% | 73.96% |
| Total Receivables | 9.28% | 14.38% | 9.53% | 3.35% | 7.41% |
| Inventory | 22.02% | 40.96% | 43.24% | 38.20% | 20.06% |
| Prepaid Expenses | 49.88% | 85.38% | 86.23% | 46.71% | 0.12% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 70.00% | -- | -- | -- | 42.86% |
| Total Current Assets | -26.46% | -18.44% | 17.94% | 39.93% | 46.11% |
|
|
|||||
| Total Current Assets | -26.46% | -18.44% | 17.94% | 39.93% | 46.11% |
| Net Property, Plant & Equipment | -15.68% | -13.15% | -10.40% | -7.49% | -7.90% |
| Long-term Investments | -- | -- | -87.56% | -86.82% | -- |
| Goodwill | -- | -- | -87.56% | -86.82% | -- |
| Total Other Intangibles | -13.59% | -13.15% | -7.05% | -7.24% | -11.85% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -4.92% | -10.32% | -5.08% | -8.54% | -9.36% |
| Total Assets | -18.58% | -14.73% | -6.65% | 0.21% | -1.33% |
|
|
|||||
| Total Accounts Payable | -20.82% | -8.67% | 60.83% | 157.98% | 21.88% |
| Total Accrued Expenses | 20.90% | 4.28% | 9.58% | 19.83% | 24.76% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -95.33% | -95.37% | 2,217.38% | 1,098.66% | 1,107.79% |
| Total Finance Division Other Current Liabilities | 8.91% | -- | -- | -- | 24.43% |
| Total Other Current Liabilities | 8.91% | -- | -- | -- | 24.43% |
| Total Current Liabilities | -61.09% | -65.05% | 237.86% | 236.81% | 218.25% |
|
|
|||||
| Total Current Liabilities | -61.09% | -65.05% | 237.86% | 236.81% | 218.25% |
| Long-Term Debt | -2.96% | -2.38% | -35.84% | -25.48% | -25.35% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -18.97% | -18.87% | -17.66% | -16.72% | -18.54% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.63% | 49.42% | 32.59% | 44.21% | -3.17% |
| Total Liabilities | -26.23% | -26.13% | 1.56% | 14.03% | 10.07% |
|
|
|||||
| Common Stock & APIC | 5.47% | 5.34% | 5.33% | 3.44% | 3.36% |
| Retained Earnings | 3.41% | 9.64% | -161.48% | -106.04% | -93.22% |
| Treasury Stock & Other | -595.12% | -396.75% | -185.63% | -15,738.16% | -10,131.58% |
| Total Common Equity | -10.95% | -2.98% | -13.82% | -10.49% | -10.55% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.95% | -2.98% | -13.82% | -10.49% | -10.55% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -10.95% | -2.98% | -13.82% | -10.49% | -10.55% |
|
|
|||||